Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt Meeting highlights from the Paediatric Committee: 21 - 23 November 2007 27 november 2007Press releaseHumanPaediatrics The European Union and the Food and Drug Administration working together to create common application for orphan designation for Medicines 26 november 2007Press releaseMedicines European Medicines Agency recommends suspension of marketing authorisation of aprotinin-containing medicines for systemic use 21 november 2007Press releaseHumanMedicines Novartis withdraws its application to extend the marketing authorisation for Zometa 20 november 2007Press releaseHuman Public statement on the cessation of marketing of exubera (Insulin human) 19 november 2007NewsHuman European Medicines Agency recommends changes in the product information for Protelos / Osseor due to the risk of severe hypersensitivity reactions 16 november 2007Press releaseHumanMedicines INFAI withdraws its marketing authorisation application for Gastromotal 16 november 2007Press releaseHuman European Medicines Agency recommends suspension of marketing authorisations for carisoprodol-containing medicinal products 16 november 2007Press releaseHumanMedicines Meeting highlights from the Committee for Medicinal Products for Human Use,12-15 November 2007 16 november 2007Press releaseHuman Committee for medicinal products for veterinary use: Meeting of 6-8 November 2007 9 november 2007Press releaseVeterinary 1 … 314 315 316 317 318 Page 318 of 380 319 320 321 322 … 380
Meeting highlights from the Paediatric Committee: 21 - 23 November 2007 27 november 2007Press releaseHumanPaediatrics
The European Union and the Food and Drug Administration working together to create common application for orphan designation for Medicines 26 november 2007Press releaseMedicines
European Medicines Agency recommends suspension of marketing authorisation of aprotinin-containing medicines for systemic use 21 november 2007Press releaseHumanMedicines
Novartis withdraws its application to extend the marketing authorisation for Zometa 20 november 2007Press releaseHuman
European Medicines Agency recommends changes in the product information for Protelos / Osseor due to the risk of severe hypersensitivity reactions 16 november 2007Press releaseHumanMedicines
INFAI withdraws its marketing authorisation application for Gastromotal 16 november 2007Press releaseHuman
European Medicines Agency recommends suspension of marketing authorisations for carisoprodol-containing medicinal products 16 november 2007Press releaseHumanMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use,12-15 November 2007 16 november 2007Press releaseHuman
Committee for medicinal products for veterinary use: Meeting of 6-8 November 2007 9 november 2007Press releaseVeterinary